Extracellular ATP: A growth factor for vascular smooth muscle cells

General Pharmacology

Volumn 31, Issue 1, 1998, Pages 1-8

  Erlinge, David ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Atherosclerosis; ATP; Hypertension; Immediate early genes; Mitogen; P2 receptor; P2U; P2Y; Phenotype; Proliferation; Review; Rstenosis; Tyrosine kinase; Tyrphostin; UTP; Vascular smooth muscle cell; Vasoconstriction

Indexed keywords

ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; ANGIOTENSIN; GROWTH FACTOR; NEUROPEPTIDE Y; NORADRENALIN; PHOSPHOLIPASE C; PHOSPHOLIPASE D; PROTEIN KINASE C; PURINE NUCLEOTIDE; PURINE RECEPTOR; TYRPHOSTIN; URIDINE TRIPHOSPHATE;

ATHEROSCLEROSIS; CATTLE; CELL CYCLE; CELL PROLIFERATION; DNA SYNTHESIS; HUMAN; HYPERTENSION; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SWINE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CELL DIVISION; CELLS, CULTURED; GROWTH SUBSTANCES; HUMANS; MITOGENS; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, PURINERGIC P1; RECEPTORS, PURINERGIC P2;

EID: 0031812161     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(97)00420-5     Document Type: Review

References (53)

1. Barnard E.A., Burnstock G., Webb T.E. G protein-coupled receptors for ATP and other nucleotides. a new receptor family Trends Pharmacol. Sci. 15:1994;67-70.
2. Bean B.P. Pharmacology and electrophysiology of ATP-activated ion channels. Trends Pharmacol. Sci. 13(3):1992;87-90.
3. Bevan R.D. Trophic effects of peripheral adrenergic nerves on vascular structure. Hypertension. 6:1984;19-26.
4. Boarder M.R., Weisman G.A., Turner J.T., Wilkinson G.F. G protein-coupled P2 purinoceptors. from molecular biology to functional responses Trends Pharmacol. Sci. 16:1995;133-139.
5. Boeynaems J.-M., Communi D., Pirotton S., Motte, S. and Parmentier. (1996) Involvement of distinct receptors in the actions of extracellular uridine nucleotides. In P2 Purinoceptors: Localization, Function and Transduction Mechanisms, pp. 266-277. Wiley, Chichester (Ciba Foundation Symposium 198).
6. Burnstock G. (1978) A basis for distinguishing two types of purinergic receptor. In Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach (Edited by Straub R. W. and Bolis L.), pp. 107-118. Raven Press, New York.
7. Chang K., Hanaoka K., Kumada M., Takuwa Y. Molecular cloning and fuctional expression of a novel P2 nucleotide receptor. J. Biol. Chem. 270:1995;26152-26158.
8. Chen Z.-P., Krull N., Xu S., Levy A., Lightman S.L. Molecular cloning and functional characterization of a rat pituitary G protein-coupled adenosine triphosphate (Atp) receptor. Endocrinology. 137:1996;1833-1840.
9. Communi D., Pirotton S., Parmentier M., Boeynaems J.-M. Cloning and functional expression of a human uridine nucleotide receptor. J. Biol. Chem. 270:1995;30849-30852.
10. Crowley S.T., Dempsey E.C., Horwitz K.B., Horwitz L.D. Platelet-induced vascular smooth muscle cell proliferation is modulated by the growth amplification factors serotonin and adenosine diphosphate. Circulation. 90:1994;1908-1918.
11. Erlinge D., Brunkwall J., Edvinsson L. Neuropeptide Y stimulates proliferation of human vascular smooth muscle cells. cooperation with noradrenaline and ATP Regul. Pept. 50:1994;259-265.
12. Erlinge D., Yoo H., Edvinsson L., Reis D. J. and Wahlestedt C. (1992) Mitogenic effects of extracellular ATP on vascular smooth muscle cells. Growth factors peptides and receptors '92. Washington spring symposium, June 1-5, 1992.
13. Erlinge D., Yoo H., Edvinsson L., Reis D. J. and Wahlestedt C. (1993) Mitogenic effects of extracellular ATP on vascular smooth muscle cells vs. other growth factors and sympathetic cotransmitters. Am. J. Physiol. 265, H1089-H1097.
14. Erlinge D., Junping Y., Wahlestedt C., Edvinsson L. Characterisation of an ATP receptor mediating mitogenesis in vascular smooth muscle cells. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 289:1995;135-149.
15. Erlinge D., Heilig M., Edvinsson L. Tyrphostin inhibits ATP stimulation of DNA synthesis, cell proliferation and c-fos expression in vascular smooth muscle cells. Br. J. Pharmacol. 118:1996;1028-1034.
16. Ethier M., Dobson J.G. Adenosine stimulation of DNA synthesis in human endothelial cells. Am. J. Physiol. 272:1997;H1470-H1479.
17. Fredholm B.B., Abbracchio M.P., Burnstock G., Daly J.W., Harden T.K., Jacobson K.A., Leff P., Williams M. Nomenclature and classification of purinoceptors. Pharmacol. Reviews. 46:1994;143-156.
18. Geisterfer A.A.T., Peach M.J., Owens G.K. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortaic smooth muscle cells. Circ. Res. 62:1988;749-756.
19. Gerwins P., Fredholm B.B. ATP and its metabolite adenosine act synergistically to mobilize intracellular calcium via the formation of inositol 1,4,5-trisphosphate in a smooth muscle cell line. J. Biol. Chem. 267:1992;16081-16087.
20. Gordon J.L. Extracellular ATP. effects, sources and fate Biochem. J. 233:1986;309-319.
21. Huwiler A., Pfeilschifter J. Stimulation of extracellular ATP and UTP of the mitogen-activated protein kinase cascade and proliferation of rat renal mesangial cells. Br. J. Pharmacol. 113:1994;1455-1463.
22. Jonzon B., Nilsson J., Fredholm B. Adenosine receptor-mediated changes in cAMP production and DNA-synthesis in cultured arterial smooth muscle cells. J. Cell. Physiol. 124:1985;451-456.
23. 2+ level and force in isolated rat aorta. Br. J. Pharmacol. 110:1993;263-267.
24. Koshiba M., Apasov S., Sverdlov V., Chen P., Erb L., Turner J.T., Weisman G.A., Sitkovsky M.V. Transient up-regulation of P2Y2 nucleotide receptor mRNA expression is an immediate early gene response in activated thymocytes. Proc. Natl. Acad. Sci. USA. 94:1997;831-836.
25. Lazarowski E.R., Watt W.C., Stutts M.J., Boucher R.C., Harden T.K. Pharmacological selectivity of the cloned human P2U-purinoceptor. potent activation by diadenosinetetraphosphate Br. J. Pharmacol. 116:1995;1619-1627.
26. Li Q., Schachter J.B., Harden T.K., Nicholas R.A. The 6H1 orphan receptor, claimed to be the p2Y5 receptor, does not mediate nucleotide-promoted second messenger responses. Biochem. Biophys. Res. Commun. 236(2):1997;455-460.
27. Lon C., Hechler B., Vial C., Leray C., Cazenave J.-P., Gachet C. The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakryoblastic cells. FEBS Lett. 403:1997;26-30.
28. Malam-Souley R., Campan M., Gadeau A.-P., Desgranges C. Exogenous ATP induces limited cell cycle progression of arterial smooth muscle cells. Am. J. Physiol. 264:1993;C783-C788.
29. Malam-Souley R., Seye C., Gadeau A.-P., Loirand G., Pillois X., Campan M., Pacaud P., Desgranges C. Nucleotide receptor P2U partially mediates ATP-induced cell cycle progression of aortic smooth muscle cells. J. Cell. Physiol. 166:1996;57-65.
30. Martin K.A., Kertesy S.B., Dubyak G.R. Down-regulation of P2U-purinergic nucleotide receptor messenger RNA expression during in vitro differentiation of human myeloid leukocytes by phorbol esters or inflammatory activators. Mol. Pharmacol. 51:1997;97-108.
31. Middaugh C.R., Mach H., Burke C.J., Volkin D.B., Dabora J.M., Tsai P.K., Bruner M.W., Ryan J.A., Marfia K.E. Nature of the interaction of growth factors with suramin. Biochemistry. 31:1992;9016-9024.
32. Miyagi Y., Kobayashi S., Ahmed A., Nishimura J., Fukui M., Kanaide H. P2U purinergic activation leads to the cell cycle progression from the G1 to the S and M phases but not from the G0 to the G1 phase in vascular smooth muscle cells in primary culture. Biochem. Biophys. Res. Commun. 222:1996;652-658. a.
33. Miyagi Y., Kobayashi S., Nishimura J., Fukui M., Kanaide H. Dual regulation of cerebrovascular tone by UTP. P2U receptor mediated contraction and endothelium-dependent relaxation Br. J. Pharmacol. 118:1996;847-856. b.
34. Neary J.T., Rathbone M.P., Cattabeni F., Abbrachio M.P., Burnstock G. Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends Neurosci. 19:1996;13-18.
35. Nicholas R.A., Watt W.C., Lazarowski E.R., Li Q., Harden T.K. Uridine nucleotide selectivity of three phospholipase C activating P2 receptors. identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor Mol. Pharmacol. 50:1996;224-229.
36. O'Connor S.E., Dainty I.A., Leff P. Further subclassification of ATP receptors based on agonist studies. Trends Pharmacol. Sci. 12:1991;137-141.
37. 2-receptor subtypes in freshly isolated and cultured aortic smooth muscle cells. Am. J. Physiol. 269:1995;30-36.
38. Pfeilschifter J., Merriweather C. Extracellular ATP and UTP activation of phospholipase D is mediated by protein kinase C-ε in rat renal mesangial cells. Br. J. Pharmacol. 110:1993;847-853.
39. Ralevic V., Burnstock G. Roles of P2-purinoceptors in the cardiovascular system. Circulation. 84:1991;1-14.
40. Rice W.R., Burton F.M., Fiedeldey D.T. Cloning and expression of the alveolar type II cell P2U-purinergic receptor. Am. J. Respir. Cell Mol. Biol. 12:1995;27-32.
41. Ross R. The pathogenesis of atherosclerosis. a perspective for the 1990s Nature. 362:1993;801-809.
42. Saiag B., Milon D., Allain H., Rault B., Van den Driessche J. Constriction of the smooth muscle of the rat tail and femoral arteries and dog saphenous vein is induced by uridine triphosphate via "pyrimidinoceptors", and by adenosine triphosphate via P2X purinoceptors. Blood Vessels. 27:1990;352-364.
43. Schulze-Lohoff E., Zanner S., Ogilvie A., Sterzel R.B. Extracellular ATP stimulates proliferation of cultured mesangial cells via P2-purinergic receptors. Am. J. Physiol. 263:1992;F374-F383.
44. Sexl V., Mancusi G., Baumgartner-Parzer S., Scutz W., Freissmuth M. Stimulation of human umbilical vein endothelial cell proliferation by A2-adenosine and β2-adrenoceptors. Br. J. Pharmacol. 114:1997;1577-1586.
45. Sjölund M., Hedin U., Sejersen T., Heldin C.-H., Thyberg J. Arterial smooth muscle cells express platelet-derived growth factor (Pdgf) A chain mRNA, secrete a PDGF-like mitogen, and bind exogenous PDGF in a phenotype and growth state-dependent manner. J. Cell. Biol. 106:1988;403-413.
46. Tawada Y., Furukawa K.-I., Shigekawa M. ATP-induced calcium transient in cultured rat aortic smooth muscle cells. J. Biochem. 102:1987;1499-1509.
47. Van Daele P., Van Coevorden A., Roger P.P., Boeynaems J.-M. Effects of adenine nucleotides on the proliferation of aortic endothelial cells. Circ. Res. 70:1992;82-90.
48. von der Weid P.-Y., Serebryakov V.N., Orallo F., Bergmann C., Snetkov V.A., Takeda K. Effects of ATP on cultured smooth muscle cells from rat aorta. Br. J. Pharmacol. 108:1993;638-645.
49. von Kugelgen I., Starke K. Evidence for two separate vasoconstriction-mediating nucleotide receptors, both distinct from the P2X-receptor, in rabbit basilar artery. a receptor for pyrimidine nucleotides and a receptor for purine nucleotides Naunyn Schmiedebergs Arch. Pharmacol. 341:1990;538-546.
50. Wang D.-J., Huang N.-N., Heppel L.A. Extracellular ATP and ADP stimulate proliferation of porcine aortic smooth muscle cells. J. Cell. Physiol. 153:1992;221-233.
51. Webb T.E., Simon J., Krishek B.J., Bateson A.N., Smart T.G., King B.F., Burnstock G., Barnard E.A. Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett. 324:1993;219-225.
52. Webb T.E., Kaplan M.G., Barnard E.A. Identification of 6H1 as a P2Y purinoceptor. P2y5 Biochem. Biophys. Res. Commun. 219:1996;105-110.
53. Yu S.-M., Chen S.-F., Lau Y.-T., Yang C.-M., Chen J.-C. Mechanism of extracellular ATP-induced proliferation of vascular smooth muscle cells. Mol. Pharmacol. 50:1996;1000-1009.